报告期内，公司监事会召开了 4 次会议，具体情况如下： 一、监事会组成情况 公司第八届监事会由 3 人组成，分别为监事会主席郑晨霞、监事 韩妙莎、职工代表监事李有修，本届监事会任期 3 年。 2024 年度监事会工作报告 2024 年度，海南椰岛（集团）股份有限公司（以下简称"公司"） 监事会严格按照《中华人民共和国公司法》《中华人民共和国证券法》 《公司章程》《公司监事会议事规则》等相关法律、法规要求，秉承 着对全体股东负责的态度，认真履行监督职责，积极有效的开展工作， 依法独立行使职权，有力促进了公司规范运作，切实维护了公司、股 东及员工的合法权益。2024 年度，监事会成员出席了全年股东大会， 列席了相关董事会会议，全面了解和掌握公司的经营情况，监督了公 司董事和高级管理人员的履职情况，有效维护了公司利益和全体股东 的合法权益，对企业的规范运作发挥了积极有效作用。现将 2024 年 度监事会履职情况报告如下。 二、监事会的工作情况 1、召开监事会会议的情况 海南椰岛（集团）股份有限公司 2024 年，监事会严格遵循《公司法》《公司章程》以及《监事 会议事规则》的相关规定，切实执行其监督职能。监事会对公司 ...

股票简称：海南椰岛 股票代码：600238 编号：2025-013 号 海南椰岛（集团）股份有限公司 关于未弥补亏损达到公司实收资本三分之一的公告 海南椰岛（集团）股份有限公司（以下简称"公司"）于2025年4 月28日召开了第八届董事会第四十六次会议，审议通过了《关于未弥 补亏损达到公司实收资本三分之一的议案》。具体情况如下 一、情况概述 根据中审亚太会计师事务所（特殊普通合伙）为公司出具的《2024 年度审计报告》，截至 2024 年 12 月 31 日，公司合并财务报表未分配 利润为-57,847.02 万元，实收股本为 44,820 万元，公司未弥补亏损 金额已超过实收股本总额的三分之一。 2024 年度公司新产品开发、生产上市、推广存在滞后，对报告期 内的销售贡献较少，整体产品销售毛利无法覆盖日常经营费用。同时， 公司原有产品定位不准确、价格体系不合理等原因，市场动销不畅， 应收款项信用减值增加且老品库存去化率较慢产生存货减值，加大了 报告期的经营亏损，以致公司 2024 年度未弥补亏损金额仍超过实收股 本总额的三分之一。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大 ...

海南椰岛（集团）股份有限公司 二、财务状况 （一）资产结构 2024 年度财务决算报告 海南椰岛（集团）股份有限公司（以下简称"公司"）2024 年度财务决算 会计报表，经中审亚太会计师事务所（特殊普通合伙）审计，已出具中审亚太审 字（2025）005717 号带有强调事项段的保留意见审计报告。现将 2024 年度公 司的财务决算情况简要报告如下： 一、主要会计数据及财务指标 （一）主要会计数据 | | | | 单位：万元 | | --- | --- | --- | --- | | 主要会计数据 | 2024 年 年 | 2023 | 本期比上年同期 | | | | | 增减(%) | | 营业收入 | 17,520.71 22,452.69 | | -21.97 | | 扣除与主营业务无关的业务收入和不具 备商业实质的收入后的营业收入 | 17,239.27 22,010.58 | | -21.68 | | 归属于上市公司股东的净利润 | -13,614.08 -14,916.13 | | 不适用 | | 归属于上市公司股东的扣除非经常性损 益的净利润 | -14,218.88 -15,087.60 | | ...

关于海南椰岛（集团）股份有限公司 非经营性资金占用及其他关联资金往来情况 汇总表的专项审计报告 目 录 1、 专项审计报告 我们按照中国注册会计师审计准则的相关规定执行了审核工作。中国注册会 计师审计准则要求我们遵守中国注册会计师职业道德守则,计划和执行审核工作 以对汇总表是否不存在重大错报获取合理保证。在审核过程中,我们实施了包括 检查会计记录、重新计算相关项目金额等我们认为必要的程序。我们相信,我们 的审核工作为发表审核意见提供了合理的基础。 我们认为,后附汇总表所载资料与我们审计海南椰岛 2024年度财务报表时 所复核的会计资料和经审计的财务报表的相关内容,在所有重大方面没有发现不 一致。 2、 附表 委托单位：海南椰岛（集团）股份有限公司 审计单位：中审亚太会计师事务所（特殊普通合伙） 联系电话：089866532987 (A 中审亚太会计师事务所 (特殊普通合伙) China Audit Asia Pacific Certified Public Accountants LLP 关于海南椰岛(集团)股份有限公司 非经营性资金占用及其他关联资金往来情况汇总表 的专项审核报告 中审亚太审字(2025)0 ...

智通财经4月29日电，海南椰岛(600238.SH)公告称，因公司2024年度经审计的扣除非经常性损益前后的 净利润孰低者为负值，且扣除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入低于 1.75亿元，触及《上海证券交易所股票上市规则》相关规定，公司股票将被实施退市风险警示。同时， 因公司2024年度内部控制审计被出具了否定意见，公司股票将被实施其他风险警示。实施退市风险警示 后，公司A股简称将变更为*ST椰岛。 海南椰岛：将被实施退市风险警示及其他风险警示 ...

海南椰岛（600238）公告，公司2024年度经审计的扣除非经常性损益前后的净利润孰低者为负值，且扣 除与主营业务无关的业务收入和不具备商业实质的收入后的营业收入低于3亿元。公司2024年度内部控 制审计被出具了否定意见，触及《上海证券交易所股票上市规则》第9.8.1条第(三)项规定。公司股票将 于2025年4月30日停牌一天，并于2025年5月6日起实施退市风险警示，股票价格的日涨跌幅限制 为"5%"。因公司最近连续3个会计年度扣除非经常性损益前后净利润孰低者均为负值，且最近一个会计 年度财务会计报告的审计报告显示公司持续经营能力存在不确定性，公司股票将被实施其他风险警示。 公司股票简称由"海南椰岛"变更为"*ST椰岛"。 ...

A股免税店板块盘初走弱，众信旅游跌超9%，海南椰岛跌超5%，步步高、友阿股份跌超4%，东百集 团、凯撒旅业、百联股份跟跌。 ...

Investment Rating - The report does not explicitly state an investment rating for the cinnamon health food industry Core Insights - The cinnamon health food industry is driven by health demand, with a broad market outlook due to the rich raw material resources and increasing consumer recognition and acceptance [4][11][14] - The industry has experienced stable historical growth, primarily influenced by limited supply increases and the need for greater consumer awareness, with price increases being the main growth driver [4][33] - Future growth is expected to be supported by policy backing and an aging population, which will enhance supply and consumer demand, leading to market expansion [4][35] Industry Definition - Cinnamon health foods are defined as health products primarily made from cinnamon, which is widely used in traditional medicine and has multiple health benefits [5] Industry Classification - The cinnamon health food industry can be classified into various forms, including liquor, capsules, tablets, granules, oral liquids, pills, pastes, and powders [6][10] Industry Characteristics - Rich raw material resources: China leads the world in cinnamon planting area and production, ensuring a stable supply for the industry [11][12] - Clear regulatory boundaries: The industry is subject to specific safety and functionality standards, providing a balanced regulatory environment that encourages innovation [13] - Sustained consumer demand: The dual role of cinnamon as both a traditional medicine and a spice enhances consumer acceptance and demand for cinnamon health foods [14] Development History - The industry has evolved from initial exploration to maturity, with significant growth driven by policy support and market demand [15][16] - The establishment of a dual-channel registration and filing mechanism for health foods has accelerated product innovation and market responsiveness [18] Industry Chain Analysis - The industry chain includes sustainable raw material sourcing, technological innovation in production, and strong downstream market demand for health products [19][20] - Upstream supply is critical, with the planting area and quality of cinnamon directly impacting the industry [20] - Midstream processing requires advanced technology to ensure product quality and market competitiveness [21] Market Size - The market size of the cinnamon health food industry grew from 1.402 billion RMB in 2020 to 1.578 billion RMB in 2024, with a compound annual growth rate of 3.00% [32] - Future projections estimate the market will reach 1.902 billion RMB by 2029, with a compound annual growth rate of 3.99% [32] Price Trends - The average price of cinnamon health foods is expected to rise from 205.01 RMB to 215.03 RMB between 2025 and 2029, driven by increased consumer demand for quality health products [36] Competitive Landscape - The industry is characterized by significant product homogeneity, with leading companies like Weisiya Health and others competing in a relatively small market [41][42] - Smaller companies may find opportunities for growth through differentiated strategies, as the market does not heavily rely on large listed companies [45]

Investment Rating - The report does not explicitly state an investment rating for the cinnamon health food industry Core Insights - The cinnamon health food industry is driven by health demand, with a broad market outlook due to the rich raw material resources and increasing consumer recognition and acceptance [4][11] - The industry has experienced stable historical growth, primarily influenced by limited supply increases and the need for greater consumer awareness, with price increases being the main growth driver [4][34] - Future growth is expected to be supported by policy backing and an aging population, which will enhance supply and elevate consumer demand, leading to market expansion [4][35] Industry Definition - Cinnamon health foods are defined as health products primarily made from cinnamon, which is widely recognized for its multiple health benefits [5] Industry Classification - The cinnamon health food industry can be categorized into various forms, including tinctures, capsules, and tablets [6] Industry Characteristics - Rich raw material resources: China leads the world in cinnamon planting area and production, ensuring a stable supply for the industry [11][12] - Clear regulatory boundaries: The industry is subject to specific safety and functionality standards, providing a balanced regulatory environment that encourages innovation [13] - Sustained consumer demand: The dual role of cinnamon as both a traditional medicine and a widely used spice enhances consumer acceptance of cinnamon health foods [14] Development History - The industry has evolved from initial exploration to a mature stage, with significant growth driven by policy support and market demand [15][16] Industry Chain Analysis - The industry chain includes sustainable raw material sourcing, technological innovation in production, and strong downstream market demand for health products [19][20] Market Size - The market size of the cinnamon health food industry grew from 1.402 billion RMB in 2020 to 1.578 billion RMB in 2024, with a compound annual growth rate of 3.00% [32] - Future projections estimate the market will expand from 1.626 billion RMB in 2025 to 1.902 billion RMB in 2029, with a compound annual growth rate of 3.99% [32] Price Trends - The average price of cinnamon health foods is expected to rise from 205.01 RMB to 215.03 RMB between 2025 and 2029, driven by increasing consumer demand for quality health products [36] Competitive Landscape - The industry is characterized by significant product homogeneity, with leading companies like Weisiya Health and others competing in a relatively fragmented market [41][42] - Smaller companies may find opportunities for growth through differentiated strategies, as the market does not heavily rely on large listed companies [45]